Lisata Therapeutics, INC. (LSTA) — DEF 14A Filings
All DEF 14A filings from Lisata Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Lisata Therapeutics Executive Compensation Revealed
— Apr 25, 2025 Risk: medium
Lisata Therapeutics, Inc. filed its DEF 14A on April 25, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing include -
Lisata Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 29, 2024 Risk: low
LISATA THERAPEUTICS, INC. (LSTA) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. The 2024 Annual Meeting of Stockholders for Lisata Therapeuti
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX